Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Palisade Bio, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +23 vs. Q1 2021
- Shares held
- 2.49M
- +2.49M vs. Q1 2021
- Total value
- $10.1M
- +$10.1M vs. Q1 2021
- New holders
- 23
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PALI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $362.4M |
| Q1 2026 | 96 | $261.7M |
| Q4 2025 | 86 | $319.4M |
| Q3 2025 | 12 | $102.8K |
| Q2 2025 | 11 | $57.5K |
| Q1 2025 | 13 | $200.9K |
| Q4 2024 | 10 | $387.7K |
| Q3 2024 | 9 | $347.4K |
| Q2 2024 | 8 | $297.7K |
| Q1 2024 | 16 | $384.6K |
| Q4 2023 | 16 | $158.3K |
| Q3 2023 | 13 | $86.6K |
| Q2 2023 | 11 | $228.7K |
| Q1 2023 | 9 | $29.8K |
| Q4 2022 | 12 | $648.0K |
| Q3 2022 | 33 | $842.0K |
| Q2 2022 | 26 | $395.0K |
| Q1 2022 | 25 | $930.0K |
| Q4 2021 | 28 | $1.70M |
| Q3 2021 | 22 | $2.03M |
| Q2 2021 | 23 | $10.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Palisade Bio, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Altium Capital Management LP | 1,824,894 | $7.43M | 1.72% | +1,824,894 | New |
| Vanguard Group Inc | 237,811 | $968.0K | 0.00% | +237,811 | New |
| Renaissance Technologies LLC | 145,300 | $591.0K | 0.00% | +145,300 | New |
| Strategic Wealth Designers | 53,129 | $216.0K | 0.08% | +53,129 | New |
| Sabby Management, LLC | 52,500 | $214.0K | 0.05% | +52,500 | New |
| State Street Corp | 28,210 | $115.0K | 0.00% | +28,210 | New |
| BlackRock Inc. | 24,707 | $101.0K | 0.00% | +24,707 | New |
| Geode Capital Management, LLC | 24,675 | $100.0K | 0.00% | +24,675 | New |
| UBS Group AG | 22,138 | $90.0K | 0.00% | +22,138 | New |
| Private Advisor Group, LLC | 21,051 | $86.0K | 0.00% | +21,051 | New |
| Virtu Financial LLC | 18,200 | $74.0K | 0.01% | +18,200 | New |
| HighTower Advisors, LLC | 16,666 | $68.0K | 0.00% | +16,666 | New |
| Citadel Advisors LLC | 10,425 | $42.0K | 0.00% | +10,425 | New |
| Morgan Stanley | 3,935 | $16.0K | 0.00% | +3,935 | New |
| Evermay Wealth Management LLC | 1,666 | $7.00K | 0.00% | +1,666 | New |
| Tower Research Capital LLC (TRC) | 909 | $4.00K | 0.00% | +909 | New |
| Wells Fargo & Company | 240 | $1.00K | 0.00% | +240 | New |
| Bank of America Corp | 3 | $0 | 0.00% | +3 | New |
| Advisor Group Holdings, Inc. | 86 | $0 | 0.00% | +86 | New |
| Sterling Investment Advisors, Ltd. | 5 | $0 | 0.00% | +5 | New |
| Centerpoint Advisors, LLC | 9 | $0 | 0.00% | +9 | New |
| Lindbrook Capital, LLC | 9 | $0 | 0.00% | +9 | New |
| Aspire Private Capital, LLC | 34 | $0 | 0.00% | +34 | New |